Aggregated human serum immunoglobulin A1 induced by neuraminidase treatment had a lower number of O-linked sugar chains on the hinge portion
- PMID: 10202952
- DOI: 10.1016/s0378-4347(98)00552-0
Aggregated human serum immunoglobulin A1 induced by neuraminidase treatment had a lower number of O-linked sugar chains on the hinge portion
Abstract
A part of human serum immunoglobulin A1(IgA1) was aggregated by treatment with neuraminidase. Aggregated IgA1 was separated from non-aggregated IgA1 by gel permeation chromatography. The prepared asialo-hinge glycopeptide (asialo-HGP) from both IgA1 subfractions was treated with beta-galactosidase to determine the number of beta-linked sugar chains attached on the hinge region. Removal of the galactose residue from asialo-HGP resulted in the HPLC separation of three major peaks. MALDI-TOFMS analysis of the glycopeptides also indicated the presence of three HGP components with three, four and five N-acetylgalactosamine (GalNAc) residues, respectively. Comparison of their relative content among the glycopeptide components showed a higher content of the HGP component with a lower number of GalNAc residues on aggregated IgA1. Thus, asialo-HGP prepared from aggregated IgA1 induced by neuraminidase treatment had an incomplete core structure of O-linked oligosaccharides. Especially, the result suggested that the reduced number of the attached O-linked oligosaccharides on IgA1 take part in phenomena such as self-aggregation of asialo-IgA1.
Similar articles
-
Estimation of the number of O-linked oligosaccharides per heavy chain of human serum IgA1 by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOFMS) analysis of the hinge glycopeptide.J Biochem. 1996 Aug;120(2):393-7. doi: 10.1093/oxfordjournals.jbchem.a021425. J Biochem. 1996. PMID: 8889826
-
Mutual separation of hinge-glycopeptide isomers bearing five N-acetylgalactosamine residues from normal human serum immunoglobulin A1 by capillary electrophoresis.J Chromatogr B Biomed Sci Appl. 1999 May 28;728(2):175-83. doi: 10.1016/s0378-4347(99)00102-4. J Chromatogr B Biomed Sci Appl. 1999. PMID: 10406203
-
Application of matrix-assisted laser desorption ionization time-of-flight mass spectrometry to the analysis of glycopeptide-containing multiple O-linked oligosaccharides.J Chromatogr B Biomed Sci Appl. 1998 May 8;709(1):145-9. doi: 10.1016/s0378-4347(98)00050-4. J Chromatogr B Biomed Sci Appl. 1998. PMID: 9653936
-
Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing.J Proteomics. 2013 Oct 30;92:299-312. doi: 10.1016/j.jprot.2013.07.013. Epub 2013 Jul 24. J Proteomics. 2013. PMID: 23891555 Free PMC article.
-
IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1.Contrib Nephrol. 2007;157:129-33. doi: 10.1159/000102454. Contrib Nephrol. 2007. PMID: 17495450 Review.
Cited by
-
Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy.Clin Exp Nephrol. 2008 Oct;12(5):332-338. doi: 10.1007/s10157-008-0054-5. Epub 2008 Apr 12. Clin Exp Nephrol. 2008. PMID: 18404247 Review.
-
The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy.Front Immunol. 2016 Apr 12;7:117. doi: 10.3389/fimmu.2016.00117. eCollection 2016. Front Immunol. 2016. PMID: 27148252 Free PMC article. Review.
-
The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.Clin Exp Immunol. 2005 Dec;142(3):569-75. doi: 10.1111/j.1365-2249.2005.02949.x. Clin Exp Immunol. 2005. PMID: 16297170 Free PMC article.
-
Immunopathogenesis of IgAN.Semin Immunopathol. 2007 Nov;29(4):427-43. doi: 10.1007/s00281-007-0089-9. Epub 2007 Sep 13. Semin Immunopathol. 2007. PMID: 17851660 Review.
-
Immunoglobulin A Glycosylation and Its Role in Disease.Exp Suppl. 2021;112:433-477. doi: 10.1007/978-3-030-76912-3_14. Exp Suppl. 2021. PMID: 34687019